Illumina (ILMN) Taps Former Pfizer (PFE) SVP Stapley as CFO
Tweet
Share
E-mailGet Alerts ILMN Hot Sheet
Join SI Premium – FREE
Illumina, Inc. (Nasdaq: ILMN) today announced it has named Marc Stapley, former Senior Vice President, Finance, at Pfizer (NYSE: PFE) and Americas Chief Financial Officer at Alcatel-Lucent (NYSE: ALU, to the position of Senior Vice President and Chief Financial Officer.
Stapley joins Illumina from Pfizer where he served as Senior Vice President responsible for global financial processes and systems, leading integration efforts in both the Wyeth and King Pharmaceutical acquisitions and providing oversight to the company’s largest technology investment program.
Stapley joins Illumina from Pfizer where he served as Senior Vice President responsible for global financial processes and systems, leading integration efforts in both the Wyeth and King Pharmaceutical acquisitions and providing oversight to the company’s largest technology investment program.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Somnigroup names Tyson Hagale president of Leggett & Platt
- New America Acquisition names new CFO and COO after leadership shift
- Fox Corporation COO to speak at Goldman Sachs conference in September
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
